Skip to content

UFP Technologies UFPT Finance Lease Liability - Undiscounted Excess Amount

Finance Lease Liability - Undiscounted Excess Amount at other companies

West Pharmaceutical Services logo
West Pharmaceutical ServicesWST

Other financials

Income statement

See full
Revenue$154.2M+4.1%
Gross profit$44.4M+5.2%
Operating income$23.4M+1.0%
Net income$17.5M+1.8%
EPS (diluted)$2.24+1.4%

Balance sheet

See full
Cash & equivalents$20.0M+42.4%
Total debt$156.1M-21.4%
Total equity$438.9M+21.7%
Total assets$674.7M+5.0%

Cash flow

See full
Operating cash flow$3.2M-76.8%
CapEx$2.9M+3.1%
Free cash flow$22.5M+151%

Valuation

See full
Market cap$1.88B-3.6%

Profitability

See full
Gross margin28.4%-0.6pp
Operating margin15.2%-0.9pp
Net margin11.3%-0.3pp
FCF margin12.3%+2.0pp

Returns & leverage

See full
Return on equity17.2%-2.2pp
Debt / equity0.4×-0.2×
Current ratio2.9×+0.3×

Where this comes from

Reported directly by UFP Technologies in its filing.

Tagged under the XBRL concept us-gaap:FinanceLeaseLiabilityUndiscountedExcessAmount.

The official record: UFP Technologies’s 10-Q, filed May 8, 2026, on SEC EDGAR. View the filing →

Ask your AI about UFP Technologies's finance lease liability - undiscounted excess amount.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is UFP Technologies's finance lease liability - undiscounted excess amount?
UFP Technologies (UFPT) reported finance lease liability - undiscounted excess amount of $0 in Q1 2026.
What does finance lease liability - undiscounted excess amount mean?
This represents the total undiscounted future cash payments required for finance leases, excluding the recognized lease liability. It provides visibility into the long-term contractual obligations for leased assets that are not yet reflected as current debt. Monitoring this helps investors understand the full scale of off-balance sheet or future lease commitments.